Abstract
Pharmacophore discovery is one of the major elements of molecular modeling in the absence of X-ray structural data. While pharmacophores initially made their debut as a means for lead discovery, more recent refinements have brought them into the domain of lead optimization, e.g. as a means to define the molecular alignment in 3D-QSAR. In this review, the experiences of over a decade of confronting and solving the challenges of pharmacophore discovery applied to actual drug discovery are summarized. Also, practical tips are described for using the author's methodology for pharmacophore discovery, DANTE.
About this chapter
Cite this chapter as:
John H. van Drie ;Pharmacophore Discovery - Lessons Learned, Frontiers in Medicinal Chemistry (2005) 2: 511. https://doi.org/10.2174/978160805205910502010511
DOI https://doi.org/10.2174/978160805205910502010511 |
Print ISSN 1567-2042 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5763 |